相关实验视频
Updated: Jun 5, 2025

05:17
Intravenous Injections in Neonatal Mice
Published on: November 11, 2014
58.4K
新生儿血栓形成中的贝米巴林:治疗剂量和安全性
Maria Sanchez-Holgado1, Mercedes Sampedro2, Carlos Zozaya2
1Department of Neonatology. La Paz University Hospital, Madrid, Spain. msholgado@salud.madrid.org.
概括
贝米帕林对新生儿血栓形成治疗有前途,但初始剂量往往需要调整以达到治疗性抗Xa水平. 过早出生的婴儿可能需要更高的贝米巴林剂量以获得有效的抗凝剂.
科学领域:
- 新生儿医学 新生儿医学
- 儿科血栓形成症 儿童血栓形成症
- 药理学 药理学是指药理学的学科.
背景情况:
- 新生儿血栓形成症在抗凝固管理中提出了独特的挑战.
- 像贝米巴林这样的低分子量肝素越来越多地被考虑用于儿科.
研究的目的:
- 评估贝米巴林剂量治疗新生儿血栓形成的疗效和安全性.
- 为了确定初始贝米帕林剂量达到治疗性抗Xa水平.
主要方法:
- 从2018年至2023年期间,对72名接受贝米巴林治疗的新生儿进行了回顾性审查.
- 分析初始和治疗性贝米巴林剂量 (IU/kg/day) 和达到治疗性目标范围 (TTR).
主要成果:
- 平均初始和治疗性贝米巴林剂量为170.5和200 IU/kg/day.
- 只有32%的初始剂量达到TTR;早产婴儿需要更高的剂量 (215 IU/kg/day).
- 不良事件很少发生 (1.4%) 并与剂量或早产无关.
结论:
- 贝米巴林是新生儿抗凝药的可行选择.
- 最初的贝米巴林剂量往往需要升级才能达到目标的抗Xa水平.
- 剂量调整可能至关重要,特别是在早产新生儿中.
相关概念视频
Therapeutic Index
4.1K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
4.1K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
608
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
608
Factors Affecting Drug Response: Overview
1.8K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.8K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
80
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
80
Drug Delivery: Parenteral Route
411
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
411

